169 related articles for article (PubMed ID: 33846428)
1. The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection.
Litjens N; Peeters A; Gestel JK; Klepper M; Betjes M
Sci Rep; 2021 Apr; 11(1):7903. PubMed ID: 33846428
[TBL] [Abstract][Full Text] [Related]
2. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
[TBL] [Abstract][Full Text] [Related]
4. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
Dos Santos DC; Campos EF; Saraiva Câmara NO; David DS; Malheiros DM
Transpl Int; 2016 Apr; 29(4):443-52. PubMed ID: 26615051
[TBL] [Abstract][Full Text] [Related]
5. Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.
Sablik KA; Litjens NHR; Klepper M; Betjes MGH
Transpl Immunol; 2019 Jun; 54():52-58. PubMed ID: 30794946
[TBL] [Abstract][Full Text] [Related]
6. The influence of NK cell-mediated ADCC: Structure and expression of the CD16 molecule differ among FcγRIIIa-V158F genotypes in healthy Japanese subjects.
Oboshi W; Watanabe T; Matsuyama Y; Kobara A; Yukimasa N; Ueno I; Aki K; Tada T; Hosoi E
Hum Immunol; 2016 Feb; 77(2):165-71. PubMed ID: 26582002
[TBL] [Abstract][Full Text] [Related]
7. Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.
Wahrmann M; Döhler B; Arnold ML; Scherer S; Mayer KA; Haindl S; Haslacher H; Böhmig GA; Süsal C
Front Immunol; 2021; 12():724331. PubMed ID: 34497614
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.
Diebold M; Vietzen H; Heinzel A; Haindl S; Herz CT; Mayer K; Doberer K; Kainz A; Faé I; Wenda S; Kühner LM; Berger SM; Puchhammer-Stöckl E; Kozakowski N; Schaub S; Halloran PF; Böhmig GA
Am J Transplant; 2024 May; 24(5):743-754. PubMed ID: 38097018
[TBL] [Abstract][Full Text] [Related]
10. SNPs rs4656317 and rs12071048 located within an enhancer in FCGR3A are in strong linkage disequilibrium with rs396991 and influence NK cell-mediated ADCC by transcriptional regulation.
Oboshi W; Watanabe T; Yukimasa N; Ueno I; Aki K; Tada T; Hosoi E
Hum Immunol; 2016 Oct; 77(10):997-1003. PubMed ID: 27338556
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the Natural Killer Cell Receptor NKG2C Encoding
Vietzen H; Döhler B; Tran TH; Süsal C; Halloran PF; Eskandary F; Herz CT; Mayer KA; Kozakowski N; Wahrmann M; Ely S; Haindl S; Puchhammer-Stöckl E; Böhmig GA
Front Immunol; 2022; 13():829228. PubMed ID: 35401541
[TBL] [Abstract][Full Text] [Related]
12. FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.
Moroi R; Endo K; Kinouchi Y; Shiga H; Kakuta Y; Kuroha M; Kanazawa Y; Shimodaira Y; Horiuchi T; Takahashi S; Shimosegawa T
Immunogenetics; 2013 Apr; 65(4):265-71. PubMed ID: 23358932
[TBL] [Abstract][Full Text] [Related]
13. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
[TBL] [Abstract][Full Text] [Related]
14. Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.
Nishiyama S; Wright AE; Lotan I; Mikami T; Paul F; Aoki M; Levy M
J Neuroinflammation; 2022 Dec; 19(1):296. PubMed ID: 36503481
[TBL] [Abstract][Full Text] [Related]
15. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
16. A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.
Fujii R; Schlom J; Hodge JW
J Neurosurg; 2018 May; 128(5):1419-1427. PubMed ID: 28753113
[TBL] [Abstract][Full Text] [Related]
17. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.
Rohatgi S; Gohil S; Kuniholm MH; Schultz H; Dufaud C; Armour KL; Badri S; Mailliard RB; Pirofski LA
mBio; 2013 Aug; 4(5):e00573-13. PubMed ID: 23982074
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
[TBL] [Abstract][Full Text] [Related]
19. ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
Betjes MGH; Sablik KA; Litjens NHR; Otten HG; de Weerd AE
Hum Immunol; 2021 Feb; 82(2):89-96. PubMed ID: 33358038
[TBL] [Abstract][Full Text] [Related]
20. Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study.
Sablik KA; Clahsen-van Groningen MC; Looman CWN; Damman J; Roelen DL; van Agteren M; Betjes MGH
Transpl Int; 2018 Aug; 31(8):900-908. PubMed ID: 29570868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
